LATE-BREAKING CLINICAL TRIALS

Moderator(s)

• 

  Kathleen Gibson, MD

  Partner
  Lake Washington Vascular Surgeons
  Vascular Surgery
  Bellevue, Washington, United States
• 

  Raghu Kolluri, MD, MS

  System Medical Director - Vascular Medicine and Vascular Laboratories
  OhioHealth Riverside Methodist Hospital
  Vascular Medicine
  Columbus, Ohio, United States

Presentations:

• 11:15am - 11:26am PT

  Impact of Junctional Reflux on the Effectiveness Of Endovenous Ablation In Patients With Great Saphenous Vein Insufficiency (JURY-2 Study)
  

  Speaker: Yana Etkin, MD – Northwell Health
• 11:26am - 11:37am PT

  Short-Term Cost Effectiveness of Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis for Intermediate-Risk Pulmonary Embolism From the PEERLESS Randomized Controlled Trial
  

  Speaker: Samuel Horr, MD
• 11:37am - 11:48am PT

  Comparison of Real-World Outcomes in Pulmonary Embolism Patients Undergoing Large Bore Mechanical Thrombectomy or Receiving Anticoagulation Alone: Insights From the Premier Healthcare Database
  

  Speaker: Jay Giri, MD, MPH – Hospital of the University of Pennsylvania
• 11:48am - 12:00pm PT

  Two-Year Clinical Outcomes From the Single-Arm Arteriovenous Graft Cohort of the WAVE Trial
  

  Speaker: Mahmood Razavi, MD – St Joseph Heart & Vascular Center